Management of pediatric sellar tumors

Pediatric Endocrinology Reviews

Volumn 5, Issue SUPPL. 2, 2008, Pages 720-726

  Jane Jr , John A ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Adenoma; Craniopharyngioma; Epidemiology; Pituitary gland; Surgery; Treatment

Indexed keywords

BROMOCRIPTINE; CABERGOLINE; DEXAMETHASONE; DOPAMINE RECEPTOR STIMULATING AGENT; GADOLINIUM; PERGOLIDE;

CANCER RADIOTHERAPY; CANCER SURGERY; CHILDHOOD CANCER; CRANIOPHARYNGIOMA; CYTOREDUCTIVE SURGERY; DRUG WITHDRAWAL; HUMAN; HYPOPHYSIS ADENOMA; MORBIDITY; PROLACTINOMA; REVIEW; SELLA TURCICA TUMOR; STEREOTACTIC RADIOSURGERY; SURGICAL MORTALITY; UNSPECIFIED SIDE EFFECT;

ADENOMA; ADOLESCENT; ADULT; CHILD; CRANIOPHARYNGIOMA; FEMALE; HUMAN GROWTH HORMONE; HUMANS; MALE; PITUITARY ACTH HYPERSECRETION; PITUITARY NEOPLASMS; PROLACTINOMA; RADIOSURGERY; RADIOTHERAPY; SURGICAL PROCEDURES, OPERATIVE;

EID: 41549084186     PISSN: 15654753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Lafferty AR, Chrousos GP. Pituitary tumors in children and adolescents. J Clin Endocrinol Metab 1999;84:4317-4323
2. Arafah BM, Nasrallah MP. Pituitary tumors: pathophysiology, clinical manifestations and management. Endocr Relat Cancer 2001;8:287-305
3. Burrow GN, Wortzman G, Rewcastle NB, Holgate RC, Kovacs K. Microadenomas of the pituitary and abnormal sellar tomograms in an unselected autopsy series. N Engl J Med 1981;304:156-158
4. Parent AD, Bebin J, Smith RR. Incidental pituitary adenomas. J Neurosurg 1981;54:228-231
5. Chambers EF, Turski PA, LaMasters D, Newton TH. Regions of low density in the contrast-enhanced pituitary gland: normal and pathologic processes. Radiology 1982;144:109-113
6. Hall WA, Luciano MG, Doppman JL, Patronas NJ, Oldfield EH. Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population. Ann Intern Med 1994;120:817-820
7. Nammour GM, Ybarra J, Naheedy MH, Romeo JH, Aron DC. Incidental pituitary macroadenoma: a population-based study. Am J Med Sci 1997;314:287-291
8. Gold EB. Epidemiology of pituitary adenomas. Epidemiol Rev 1981;3:163-183
9. Kane LA, Leinung MC, Scheithauer BW, Bergstralh EJ, Laws ER Jr, Groover RV, Kovacs K, Horvath E, Zimmerman D. Pituitary adenomas in childhood and adolescence. J Clin Endocrinol Metab 1994;79:1135-1140
10. Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM. The descriptive epidemiology of craniopharyngioma. J Neurosurg 1998;89:547-551
11. Jagannathan J, Dumont AS, Jane JA Jr. Diagnosis and management of pediatric sellar lesions. Front Horm Res 2006;34:83-104
12. Mindermann T, Wilson CB. Pediatric pituitary adenomas. Neurosurgery 1995;36:259-268; discussion 269
13. Jagannathan J, Dumont AS, Jane JA Jr, Laws ER Jr. Pediatric sellar tumors: diagnostic procedures and management. Neurosurg Focus 2005;18:E6
14. Boop FA, Teo C, Pihoker K. Pediatric pituitary tumors. In: Krisht AF, Tindall GT, eds. Comprehensive Management of Pituitary Disorders. Philadelphia, PA: Lippincott, Williams & Wilkins 1999:315-326
15. Smith MV, Laws ER Jr. Magnetic resonance imaging measurements of pituitary stalk compression and deviation in patients with nonprolactin- secreting intrasellar and parasellar tumors: lack of correlation with serum prolactin levels. Neurosurgery 1994;34:834-839; discussion 839
16. Webster J, Piscitelli G, Polli A, Ferrari CI, Ismail I, Scanlon MF. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group. N Engl J Med 1994;331:904-909
17. Feigenbaum SL, Downey DE, Wilson CB, Jaffe RB. Transsphenoidal pituitary resection for preoperative diagnosis of prolactin-secreting pituitary adenoma in women: (ong term follow-up. J Clin Endocrinol Metab 1996;81:1711-1719
18. Randall RV, Laws ER Jr, Abboud CF, Ebersold MJ, Kao PC, Scheithauer BW. Transsphenoidal microsurgical treatment of prolactin-producing pituitary adenomas. Results in 100 patients. Mayo Clin Proc 1983;58:108-121
19. Gokalp HZ, Deda H, Attar A, Ugur HC, Arasil E, Egemen N. The neurosurgical management of prolactinomas. J Neurosurg Sci 2000;44:128-132
20. Molitch ME. Pathologic hyperprolactinemia. Endocrinol Metab Clin North Am 1992;21:877-901
21. Magiakou MA, Mastorakos G, Gomez MT, Rose SR, Chrousos GP. Suppressed spontaneous and stimulated growth hormone secretion in patients with Cushing's disease before and after surgical cure. J Clin Endocrinol Metab 1994;78:131-137
22. Nieman LK, Ilias I. Evaluation and treatment of Cushing's syndrome. Am J Med 2005;118:1340-1346
23. Newell-Price J, Trainer P, Besser M, Grossman A. The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states. Endocr Rev 1998;19:647-672
24. Lienhardt A, Grossman AB, Dacie JE, Evanson J, Huebner A, Afshar F, Plowman PN, Besser GM, Savage MO. Relative contributions of inferior petrosal sinus sampling and pituitary imaging in the investigation of children and adolescents with ACTH-dependent Cushing's syndrome. J Clin Endocrinol Metab 2001;86:5711-5714
25. Oldfield EH, Doppman JL, Nieman LK, Chrousos GP, Miller DL, Katz DA, Cutler GB Jr, Loriaux DL. Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome. N Engl J Med 1991;325:897-905
26. Kanter AS, Diallo AO, Jane JA Jr, Sheehan JP, Asthagiri AR, Oskouian RJ, Okonkwo DO, Sansur CA, Vance ML, Rogol AD, Laws ER Jr. Single-center experience with pediatric Cushing's disease. J Neurosurg 2005;103:413-420
27. Abe T, Tara LA, Ludecke DK. Growth hormone-secreting pituitary adenomas in childhood and adolescence: features and results of transnasal surgery. Neurosurgery 1999;45:1-10
28. Laws ER, Vance ML, Thapar K. Pituitary surgery for the management of acromegaly. Horm Res 2000;53 (Suppl 3):71-75
29. Shimon I, Cohen ZR, Ram Z, Hadani M. Transsphenoidal surgery for acromegaly: endocrinological follow-up of 98 patients. Neurosurgery 2001;48:1239-1243; discussion 1244-1235
30. Kreutzer J, Vance ML, Lopes MB, Laws ER Jr. Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria. J Clin Endocrinol Metab 2001;86:4072-4077
31. Gittoes NJ, Sheppard MC, Johnson AP, Stewart PM. Outcome of surgery for acromegaly-the experience of a dedicated pituitary surgeon. Qjm 1999;92:741-745
32. Swearingen B, Barker FG 2nd, Katznelson L, Bitler BM, Grinspoon S, Klibanski A, Moayeri N, Black PM, Zervas NT. Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J Clin Endocrinol Metab 1998;83:3419-3426
33. Matthews FD. Intraventricular craniopharyngioma. AJNR Am J Neuroradiol 1983;4:984-985
34. Van den Berge JH, Blaauw G, Breeman WA, Rahmy A, Wijngaarde R. Intracavitary brachytherapy of cystic craniopharyngiomas. J Neurosurg 1992;77:545-550
35. Hasegawa T, Kondziolka D, Hadjipanayis CG, Lunsford LD. Management of cystic craniopharyngiomas with phosphorus-32 intracavitary irradiation. Neurosurgery 2004;54:813-820; discussion 820-812
36. Pollock BE, Lunsford LD, Kondziolka D, Levine G, Flickinger JC. Phosphorus-32 intracavitary irradiation of cystic craniopharyngiomas: current technique and long-term results. Int J Radiat Oncol Biol Phys 1995;33:437-446
37. Voges J, Sturm V, Lehrke R, Treuer H, Gauss C, Berthold F. Cystic craniopharyngioma: long-term results after intracavitary irradiation with stereotactically applied colloidal beta-emitting radioactive sources. Neurosurgery 1997;40:263-269; discussion 269-270
38. Takahashi H, Nakazawa S, Shimura T. Evaluation of postoperative intratumoral injection of bleomycin for craniopharyngioma in children. J Neurosurg 1985;62:120-127
39. Hader WJ, Steinbok P, Hukin J, Fryer C. Intratumoral therapy with bleomycin for cystic craniopharyngiomas in children. Pediatr Neurosurg 2000;33:211-218
40. Frank F, Fabrizi AP, Frank G, Fioravanti A. Stereotactic management of craniopharyngiomas. Stereotact Funct Neurosurg 1995;65:176-183
41. Merchant TE, Kiehna EN, Kun LE, Mulhern RK, Li C, Xiong X, Boop FA, Sanford RA. Phase II trial of conformal radiation therapy for pediatric patients with craniopharyngioma and correlation of surgical factors and radiation dosimetry with change in cognitive function. J Neurosurg 2006;104:94-102
42. Merchant TE, Mulhern RK, Krasin MJ, Kun LE, Williams T, Li C, Xiong X, Khan RB, Lustig RH, Boop FA, Sanford RA. Preliminary results from a phase II trial of conformal radiation therapy and evaluation of radiation-related CNS effects for pediatric patients with localized ependymoma. J Clin Oncol 2004;22:3156-3162
43. Amendola BE, Wolf A, Coy SR, Amendola MA. Role of radiosurgery in craniopharyngiomas: a preliminary report. Med Pediatr Oncol 2003;41:123-127
44. Chiou SM, Lunsford LD, Niranjan A, Kondziolka D, Flickinger JC. Stereotactic radiosurgery of residual or recurrent craniopharyngioma, after surgery, with or without radiation therapy. Neuro Oncol 2001;3:159-166
45. Chung WY, Pan DH, Shiau CY, Guo WY, Wang LW. Gamma knife radiosurgery for craniopharyngiomas. J Neurosurg 2000;93(Suppl 3):47-56
46. Mokry M. Craniopharyngiomas: A six year experience with Gamma Knife radiosurgery. Stereotact Funct Neurosurg 1999;72(Suppl 1):140-149
47. Ulfarsson E, Lindquist C, Roberts M, Rahn T, Lindquist M, Thoren M, Lippitz B. Gamma knife radiosurgery for craniopharyngiomas: long-term results in the first Swedish patients. J Neurosurg 2002;97:613-622
48. Sheehan JP, Niranjan A, Sheehan JM, Jane JA Jr, Laws ER, Kondziolka D, Flickinger J, Landolt AM, Loeffler JS, Lunsford LD. Stereotactic radiosurgery for pituitary adenomas: an intermediate review of its safety, efficacy, and role in the neurosurgical treatment armamentarium. J Neurosurg 2005;102:678-691
49. DeVile CJ, Grant DB, Hayward RD, Stanhope R. Growth and endocrine sequelae of craniopharyngioma. Arch Dis Child 1996;75:108-114
50. Marchal JC, Klein O, Thouvenot P, Bernier V, Moret C, Chastagner P. Individualized treatment of craniopharyngioma in children: ways and means. Childs Nerv Syst 2005;21:655-659
51. Semple PL, Laws ER Jr. Complications in a contemporary series of patients who underwent transsphenoidal surgery for Cushing's disease. J Neurosurg 1999;91:175-179
52. Curtis J, Daneman D, Hoffman HJ, Ehrlich RM. The endocrine outcome after surgical removal of craniopharyngiomas. Pediatr Neurosurg 1994;21(Suppl 1):24-27
53. Karavitaki N, Warner JT, Marland A, Shine B, Ryan F, Arnold J, Turner HE, Wass JA. GH replacement does not increase the risk of recurrence in patients with craniopharyngioma. Clin Endocrinol (Oxf) 2006;64:556-560
54. Niu DM, Guo WY, Pan HC, Wong TT. Rapid enlargement of a residual craniopharyngioma during short-term growth hormone replacement. Childs Nerv Syst 2002;18:164-165
55. Darendeliler F, Karagiannis G, Wilton P, Ranke MB, Albertsson-Wikland K, Anthony Price D, On Behalf Of The Kigs International B. Recurrence of brain tumours in patients treated with growth hormone: analysis of KIGS (Pfizer International Growth Database). Acta Paediatr 2006;95:1284-1290
56. Moshang T Jr, Rundle AC, Graves DA, Nickas J, Johanson A, Meadows A. Brain tumor recurrence in children treated with growth hormone: the National Cooperative Growth Study experience. J Pediatr 1996;128:S4-7
57. Uchino Y, Saeki N, Iwadate Y, Yasuda T, Konda S, Watanabe T, Wada K, Kazukawa I, Higuchi Y, Iuchi T, Tatsuno I, Yamaura A. Recurrence of sellar and suprasellar tumors in children treated with hGH - relation to immunohistochemical study on GH receptor. Endocr J 2000;47(Suppl):S33-S36